Impact of chromogranin A measurement in the work-up of neuroendocrine tumors

Author： Baudin E. Bidart J. Bachelot A. Ducreux M. Elias D. Ruffié P. Schlumberger M.

ISSN： 0923-7534

Source： Annals of Oncology, Vol.12, Iss.2, 2001-02, pp. : 79-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical significance of blood chromogranin A measurement in neuroendocrine tumours

By Seregni E. Ferrari L. Bajetta E. Martinetti A. Bombardieri E.

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 69-72

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of chromogranin A determined by three different procedures in patients with benign diseases, neuroendocrine tumors and other malignancies

By Molina Rafael

Tumor Biology, Vol. 32, Iss. 1, 2011-02 ,pp. : 13-22

Springer Publishing Company

Access to resources Recommend Favorite

NEUROENDOCRINE TUMORS

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 55-56

Informa Healthcare

Access to resources Recommend Favorite

Prognostic impact of p16 and p21 on gastroenteropancreatic neuroendocrine tumors

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1641-1645

Spandidos Publications

Access to resources Recommend Favorite

Impact of the tumor microenvironment in predicting postoperative hepatic recurrence of pancreatic neuroendocrine tumors

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2753-2759

Spandidos Publications

Access to resources Recommend Favorite